Data / Form D filings / VISUM PHARMA, INC.
VISUM PHARMA, INC.: Form D filings
VISUM PHARMA, INC., a pharmaceuticals company in Stamford, CT, filed 2 Form D notices with the SEC between 2021 and 2023. The latest, on September 13, 2023, reports $50,000 sold of a $300,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 48 GURLEY ROAD, Stamford, CT, 06902
- Phone
- (914) 673-5570
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b), Securities Act section 4(a)(5)
- SEC identifier (CIK)
- 1883978
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 13, 2023 | New notice | $300,000 | $50,000 | $250,000 | 1 | Sep 12, 2023 | sec.gov |
| Nov 2, 2021 | New notice | $2,500,000 | $1,200,000 | $1,300,000 | 1 | Oct 29, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bernard J Peperstraete | Director | |
| Peter J Vanderklish | Director | |
| John J Costantino | Director | |
| Alex J Cuomo | Executive Officer | |
| William J Gedale | Executive Officer, Director | |
| Mark Smith | Executive Officer |
Other pharmaceuticals companies in Connecticut that filed recently
- Thetis Pharmaceuticals LLC $560,300 · Oct 13, 2026
- Inventure, LLC $82,345 · Sep 3, 2026
Every Form D from the week of Sep 11, 2023 · All recent filings in Connecticut · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what VISUM PHARMA, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.